Upgrade to SI Premium - Free Trial

Citi Opens Cat Call on Summit Therapeutics plc (SMMT)

May 22, 2026 5:02 AM
Citi analyst Yigal Nochomovitz reiterated a Buy rating and $40.00 price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Trader Talk